Novo Nordisk the company credited with ushering in the current weight-loss drug revolution when it launched its blockbuster diabetes treatment Ozempic in 2017 is working on its next act, a weight-loss drug called CagriSema
With current Category 2 status, double-check that a pharmacy is allowed to sell it right now, and keep an eye on the FDAs July 2026 meeting
Reduced expression of G(i) in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release
When you choose a brand that values transparency, you are investing in your long-term health with peace of mind
PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after your first month) to identify genetic variants affecting GLP-1 receptor function, appetite regulation, and metabolic pathways
While the therapy is relatively new, its already earning immense recognition for the ability to lose weight easily